Abstract
Photosensitized biological processes, as applied in photodynamic therapy, are based on light-triggered generation of molecular singlet oxygen by a membrane-residing sensitizer. Most of the sensitizers currently used are hydrophobic or amphiphilic porphyrins and their analogs. The possible activity of the short-lived singlet oxygen is limited to the time it is diffusing in the membrane, before it emerges into the aqueous environment. In this paper we demonstrate the enhancement of the photosensitization process that is obtained by newly synthesized protoporphyrin derivatives, which insert their tetrapyrrole chromophore deeper into the lipid bilayer of liposomes. The insertion was measured by fluorescence quenching by iodide and the photosensitization efficiency was measured with 9,10-dimethylanthracene, a fluorescent chemical target for singlet oxygen. We also show that when the bilayer undergoes a melting phase transition, or when it is fluidized by benzyl alcohol, the sensitization efficiency decreases because of the enhanced diffusion of singlet oxygen. The addition of cholesterol or of dimyristoyl phosphatydilcholine to the bilayer moves the porphyrin deeper into the bilayer; however, the ensuing effect on the sensitization efficiency is different in these two cases. These results could possibly define an additional criterion for the choice and design of hydrophobic, membrane-bound photosensitizers.
Original language | English |
---|---|
Pages (from-to) | 2101-2110 |
Number of pages | 10 |
Journal | Biophysical Journal |
Volume | 82 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2002 |
Bibliographical note
Funding Information:We acknowledge the support (grant No. 9800364) of the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel (to B.E.), and National Institutes of Health grant HL-22252 (to K.M.S.). B. Ehrenberg also acknowledges the support of the Michael David Falk Chair in Laser Phototherapy.
Funding
We acknowledge the support (grant No. 9800364) of the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel (to B.E.), and National Institutes of Health grant HL-22252 (to K.M.S.). B. Ehrenberg also acknowledges the support of the Michael David Falk Chair in Laser Phototherapy.
Funders | Funder number |
---|---|
Michael David Falk Chair | |
National Institutes of Health | |
National Heart, Lung, and Blood Institute | R01HL022252 |
United States-Israel Binational Science Foundation |